Source: PRSYNC

Press Release: Oxford BioTherapeutics : Oxford BioTherapeutics Ltd - Product Pipeline Review - 2014

Oxford BioTherapeutics Ltd - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Oxford BioTherapeutics Ltd - Product Pipeline Review - 2014', provides an overview of the Oxford BioTherapeutics Ltd's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Oxford BioTherapeutics Ltd's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Christian Rohlff's photo - Founder & CEO of OBT

Founder & CEO

Christian Rohlff

CEO Approval Rating

86/100

OBT is a biotechnology company that focuses on the discovery and development of therapeutics for the treatment of cancer. Read more